Upgrade to SI Premium - Free Trial

Regeneron Pharma (REGN) PT Lowered to $921 at Bernstein SocGen

April 8, 2026 7:59 AM
Bernstein SocGen Group analyst William Pickering lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $921.00 (from $925.00) while ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change